de Torres-Sánchez Alejandra, Ampudia-Blasco Francisco J, Murillo Serafín, Bellido Virginia, Amor Antonio J, Mezquita-Raya Pedro
Department of Endocrinology and Nutrition, Hospital Universitario Torrecárdenas, Almería, Spain.
Department of Medicine, Medicine Faculty, University of Valencia (UV), Valencia, Spain.
Diabetes Ther. 2025 Apr;16(4):569-589. doi: 10.1007/s13300-025-01703-0. Epub 2025 Feb 28.
For decades, glycaemic variability (GV) was ignored in clinical practice because its precise assessment was challenging and there were no specific recommendations to reduce it. However, the current widespread use of continuous glucose monitoring (CGM) systems has changed this situation. Associations between high GV and risk of hypoglycaemia, onset of macro- and microvascular complications and mortality have been described in type 1 diabetes (T1D). It is therefore important to identify the causes of excessive glycaemic excursions and make recommendations for people with T1D to achieve better glycaemic management by minimising GV in both the short term and the long term.
To achieve these aims, a panel comprising four endocrinologists, one diabetes nurse educator and one nutritionist worked together to reach a consensus on the detection of triggers of GV and propose clinical guidelines to reduce GV and improve glycaemic management by reducing the risk of hypoglycaemias.
In total, four different areas of interest were identified, in which the insufficient education and/or training of people with T1D could lead to higher GV: physical activity; dietary habits; insulin therapy, especially when pump-based systems are not used; and other causes of GV increase. Practical, easy-to-follow recommendations to reduce GV in daily activities were then issued, with the aim of enabling people with T1D to reduce either hypoglycaemia or hyperglycaemia episodes. By doing this, their quality of life may be improved, and progression of chronic complications may be prevented or delayed.
几十年来,血糖变异性(GV)在临床实践中一直被忽视,因为其精确评估具有挑战性,且没有降低血糖变异性的具体建议。然而,目前持续葡萄糖监测(CGM)系统的广泛使用改变了这种情况。在1型糖尿病(T1D)中,已描述了高血糖变异性与低血糖风险、大血管和微血管并发症的发生以及死亡率之间的关联。因此,确定血糖过度波动的原因并为1型糖尿病患者提供建议,以通过在短期和长期内最小化血糖变异性来实现更好的血糖管理非常重要。
为实现这些目标,一个由四名内分泌学家、一名糖尿病护士教育者和一名营养师组成的小组共同努力,就血糖变异性触发因素的检测达成共识,并提出临床指南,以通过降低低血糖风险来减少血糖变异性并改善血糖管理。
总共确定了四个不同的关注领域,其中1型糖尿病患者教育和/或培训不足可能导致更高的血糖变异性:体育活动;饮食习惯;胰岛素治疗,尤其是在不使用基于泵的系统时;以及其他血糖变异性增加的原因。然后发布了在日常活动中降低血糖变异性的实用、易于遵循的建议,目的是使1型糖尿病患者减少低血糖或高血糖发作。通过这样做,他们的生活质量可能会得到改善,慢性并发症的进展可能会得到预防或延迟。